Amy L. Burroughs

Chief Executive Officer

Amy L. Burroughs (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in TERN. The largest single filing was $2.7M of TERN (71,339 sh × $38.10, as filed), executed Jan 5.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.4M

shares × price, as filed

Last traded

Mar 16

Filed Mar 17

Open performance→

Volume by month

Buys $110K Sells $6.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 4 filings

Sector per market data · by filing · past 12 months

Most traded names

TERN TERN TERN · 1 buy · 4 sells 5 filings

Recent filings

TERNSALE Terns Pharmaceuticals, Inc. View filing → $681K
14,583 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET TERNSALE Terns Pharmaceuticals, Inc. View filing → $482K
12,242 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET TERNSALE Terns Pharmaceuticals, Inc. View filing → $2.5M
68,749 sh across 2 lots
Exec Jan 15
Filed Jan 16 · 5:30 PM ET TERNSALE Terns Pharmaceuticals, Inc. View filing → $2.7M
71,339 sh × $38.10
Exec Jan 5
Filed Jan 6 · 5:30 PM ET TERNPURCHASE Terns Pharmaceuticals, Inc. View filing → $110K
15,450 sh × $7.15
Exec Dec 5 2024
Filed Dec 9 2024 · 5:30 PM ET